Beauty Health Company (NASDAQ: SKIN) has seen a decline in its stock price by -5.56 in relation to its previous close of 1.53. However, the company has experienced a -3.67% decline in its stock price over the last five trading sessions. businesswire.com reported 2024-09-16 that OAKLAND, Calif.–(BUSINESS WIRE)–e.l.f. SKIN launches today its most ambitious brand campaign to date: “Divine Skintervention.” e.l.f. SKIN is positioned as the ultimate salvation for common skincare transgressions, offering a path to redemption for all skin types. In a vibrant, comedic exploration of skincare temptations, the campaign delves into the everyday skincare slip-ups —from pimple picking to the oh-so-relatable habit of sleeping in makeup. Actress and comedian Megan Stalter is the mi.
Is It Worth Investing in Beauty Health Company (NASDAQ: SKIN) Right Now?
Additionally, the 36-month beta value for SKIN is 0.96. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 7 rating it as “hold,” and 3 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SKIN is 77.34M and currently, short sellers hold a 13.31% ratio of that float. The average trading volume of SKIN on September 20, 2024 was 1.62M shares.
SKIN’s Market Performance
The stock of Beauty Health Company (SKIN) has seen a -3.67% decrease in the past week, with a -9.12% drop in the past month, and a -19.27% fall in the past quarter. The volatility ratio for the week is 8.25%, and the volatility levels for the past 30 days are at 12.65% for SKIN. The simple moving average for the last 20 days is -10.61% for SKIN stock, with a simple moving average of -45.37% for the last 200 days.
Analysts’ Opinion of SKIN
Many brokerage firms have already submitted their reports for SKIN stocks, with Jefferies repeating the rating for SKIN by listing it as a “Hold.” The predicted price for SKIN in the upcoming period, according to Jefferies is $1.50 based on the research report published on November 15, 2023 of the previous year 2023.
SKIN Trading at -11.63% from the 50-Day Moving Average
After a stumble in the market that brought SKIN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.72% of loss for the given period.
Volatility was left at 12.65%, however, over the last 30 days, the volatility rate increased by 8.25%, as shares sank -3.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -20.92% lower at present.
During the last 5 trading sessions, SKIN fell by -3.00%, which changed the moving average for the period of 200-days by -51.17% in comparison to the 20-day moving average, which settled at $1.6137. In addition, Beauty Health Company saw -53.54% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SKIN starting from SAUNDERS BRENT L, who purchase 40,450 shares at the price of $1.08 back on Aug 12 ’24. After this action, SAUNDERS BRENT L now owns 5,921,769 shares of Beauty Health Company, valued at $43,686 using the latest closing price.
Stock Fundamentals for SKIN
Current profitability levels for the company are sitting at:
- -0.38 for the present operating margin
- 0.33 for the gross margin
The net margin for Beauty Health Company stands at -0.23. The total capital return value is set at -0.22. Equity return is now at value -72.45, with -9.74 for asset returns.
Based on Beauty Health Company (SKIN), the company’s capital structure generated 0.89 points at debt to capital in total, while cash flow to debt ratio is standing at 0.0. The debt to equity ratio resting at 8.02. The interest coverage ratio of the stock is -11.36.
Currently, EBITDA for the company is -91.48 million with net debt to EBITDA at -2.17. When we switch over and look at the enterprise to sales, we see a ratio of 1.09. The receivables turnover for the company is 7.21for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.49.
Conclusion
In conclusion, Beauty Health Company (SKIN) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
